Agilent Technologies (A)
(Delayed Data from NYSE)
$139.04 USD
-3.82 (-2.67%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $138.98 -0.06 (-0.04%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
A 139.04 -3.82(-2.67%)
Will A be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for A based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for A
Ametek (AME) Beats Q2 Earnings Estimates
Cognex Corporation (CGNX) Q2 Earnings and Revenues Top Estimates
A: What are Zacks experts saying now?
Zacks Private Portfolio Services
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
Why Is Agilent (A) Down 0.5% Since Last Earnings Report?
New Strong Sell Stocks for June 7th
Other News for A
Agilent gets FDA approval for Tecelra companion diagnostic
Agilent receives FDA approval for MAGE-A4 IHC 1F9 pharmDx
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
Insider Sale: President and CEO Padraig Mcdonnell Sells Shares of Agilent Technologies Inc (A)
IN BRIEF: Agilent acquires artificial intelligence company Sigsense